Glow Lifetech Corp. (GLWLF)
Glow Lifetech Corp. operates in the Biotechnology industry of the Healthcare sector, headquartered in Etobicoke, ON, CA. The stock last traded at $0.04, up 0.00% on the session, giving a market capitalisation of $7.1M. On trailing twelve-month figures it carries a trailing P/E of -19.57, a net margin of -23.7%. Its beta of 1.47 implies it has historically moved more than the broad market.
Glow Lifetech Corp. operates as a biotechnology enterprise concentrating on the development and manufacturing of nutraceutical and cannabinoid-derived products throughout North America. The company brings to market two primary innovations: its MyCell Enhanced technology, which facilitates the efficient delivery of nutrients from nutraceuticals and cannabis, and a Cannabis Smart Consumption System, designed to aid individuals and medical patients in the storage, tracking, management, and consumption of cannabis products. Glow Lifetech holds exclusive rights across North America for the production, marketing, and distribution of specific micellization technology applicable to cannabis and hemp compounds, as well as curcumin, vitamin K, and iron. Additionally, the company undertakes the specialized processing of ingredients to create micellized substances from select vitamins, nutraceuticals, and cannabis extracts. This advanced process significantly enhances the absorption and water solubility of fat-soluble compounds, enabling nearly 100% bioavailability. Established in 2018, its operations are headquartered in Toronto, Canada.
Glow Lifetech Corp. is most often compared with the following Healthcare names: